AGIOS PHARMACEUTICALS

Lobbying for AGIOS PHARMACEUTICALS · Pharmacy, Medicare/Medicaid, Health Issues

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $30,000.00 expenses · posted Jul 20, 2026

Lobbying activity 3

Health Issues

Sickle Cell Policy Biotech Innovation

Medical/Disease Research/Clinical Labs

Biotech Innovation

Medicare/Medicaid

Medicaid Reform

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.